Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
33.68
+0.11 (0.33%)
At close: Aug 1, 2025, 4:00 PM
34.99
+1.31 (3.89%)
After-hours: Aug 1, 2025, 6:52 PM EDT

Company Description

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products.

The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development.

It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution.

In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses.

Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody.

The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Twist Bioscience Corporation
Twist Bioscience logo
CountryUnited States
Founded2013
IPO DateOct 31, 2018
IndustryDiagnostics & Research
SectorHealthcare
Employees923
CEOEmily Leproust

Contact Details

Address:
681 Gateway Boulevard
South San Francisco, California 94080
United States
Phone800 719 0671
Websitetwistbioscience.com

Stock Details

Ticker SymbolTWST
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearOctober - September
Reporting CurrencyUSD
CIK Code0001581280
CUSIP Number90184D100
ISIN NumberUS90184D1000
Employer ID46-2058888
SIC Code2836

Key Executives

NamePosition
Dr. Emily Marine Leproust Ph.D.Co-Founder, Board Chair and Chief Executive Officer
Dr. Patrick John Finn Ph.D.President and Chief Operating Officer
Adam LaponisChief Financial Officer
Dennis Cho J.D.Senior Vice President, Chief Legal Officer and Corporate Secretary
Paula GreenSenior Vice President of Human Resources
Robert F. WernerVice President and Chief Accounting Officer
Siyuan ChenChief Technology Officer
Dr. Michael Fero Ph.D.Chief Information Officer
Nicole MorenoSenior Vice President of Sales and Support
Angela BittingChief Corporate Responsibility Officer and Senior Vice President of Corporate Affairs

Latest SEC Filings

DateTypeTitle
Jul 23, 2025144Filing
Jul 9, 2025144Filing
Jul 2, 2025144Filing
Jul 2, 2025144Filing
Jul 2, 2025144Filing
Jul 2, 2025144Filing
Jun 20, 2025144Filing
Jun 20, 2025144Filing
Jun 20, 2025144Filing
Jun 16, 2025144Filing